supported by the National Natural Science Foundation of China (Nos.81973301, 82003732 and 81773701);the Medical Research Project of Jiangsu Commission of Health (No.ZDA2020006, China);the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No.18KJA310004);the Major Project of Nanjing Medical University (No.NMUD2018008, China);the Postgraduate Research and Practice Innovation Program of Jiangsu Province (Nos.KYCX19_1121 and KYCX20_1417, China);Priority Academic Program Development of Jiangsu Higer Education Institutions (China)
The mechanism of sphingosine-1-phosphate(S1P)-mediated phagocytosis remains unknown.Here,we found that S1P or FTY720(an analog of S1P)promoted microglial phagocytosis in stroke independent of S1PRs.First,we used compu...
financially supported by the Drug Innovation Major Project(No.2018ZX09711001-005-012,China);National Key R&D Program of China(No.2018YFC1706403);CAMS Innovation Fund for Medical Sciences(No.2016-I2M-2-002,China);Disciplines construction project(No.201920200802,China)
FTY720 and IMMH002,prodrugs for sphingosine-1-phosphate receptor 1(S1P1)agonists,show inadequate and inconsistent levels of phosphorylation in humans compared to that in rats.In this study,FTY720 or IMMH002 analogues(...
financially supported by National Natural Science Foundation of China(No.81102322)
An efficient method for mono-phosphorylation of 2 (KRP203) using cbz-protection, dibenzylphosphoryl chloride and TMSI affording 2-P (KRP203-P) was developed. We applied the present method to the synthesis of KRP20...